Strength
25 mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
64764025030
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
4/23/2025
Active Ingredients
ALOGLIPTIN BENZOATEApproval Type
New Drug (NDA)
FDA Application
NDA022271On Market Since
1/25/2013
Pharmacological Classes
Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
ZITUVIMET XR 50-1,000 MG TABLET
Brand
70710180506•Zydus Pharmaceuticals (USA) Inc.
$5.0263
per EA
ZITUVIMET 50-1,000 MG TABLET
Brand
70710178706•Zydus Pharmaceuticals (USA) Inc.
$5.0308
per EA
ZITUVIMET 50-500 MG TABLET
Brand
70710178606•Zydus Pharmaceuticals (USA) Inc.
$5.0779
per EA
JANUMET XR 50-1,000 MG TABLET
Brand
00006008061•Merck Sharp & Dohme LLC
$5.2761
per EA
JANUMET XR 50-1,000 MG TABLET
Brand
00006008062•Merck Sharp & Dohme LLC
$5.2761
per EA
JANUMET XR 50-1,000 MG TABLET
Brand
00006008082•Merck Sharp & Dohme LLC
$5.2761
per EA
JANUMET 50-1,000 MG TABLET
Brand
00006057761•Merck Sharp & Dohme LLC
$5.2792
per EA
JANUMET 50-1,000 MG TABLET
Brand
00006057762•Merck Sharp & Dohme LLC
$5.2792
per EA
JANUMET 50-1,000 MG TABLET
Brand
00006057782•Merck Sharp & Dohme LLC
$5.2792
per EA
JANUMET XR 50-500 MG TABLET
Brand
00006007861•Merck Sharp & Dohme LLC
$5.2815
per EA